Target intelligence / Profile preview

Rat sarcoma virus oncogene homolog (Ras) (Ras)

Target
Ras
Molecular classification
Small GTPase, Enzyme, Signal transducer, G protein
01

Overview

Ras proteins are small GTPases that function as molecular switches in cellular signaling, cycling between an inactive GDP-bound state and an active GTP-bound state [Wikipedia, NIH]. They are critical for regulating pathways like MAPK and PI3K, which control cell growth, survival, and differentiation [Dana-Farber, NIH]. Mutations in Ras genes, particularly KRAS, HRAS, and NRAS, are among the most common drivers of human cancer, occurring in approximately 20-30% of all tumors [NIH, BMJ]. These mutations typically lock the protein in a constitutively active state, leading to uncontrolled cell proliferation [Dana-Farber, NIH]. Historically considered "undruggable" due to the lack of traditional binding pockets, recent breakthroughs have led to the development of allele-specific inhibitors like sotorasib and adagrasib, which target the KRAS G12C mutation [BMJ, NIH].

Other names
KRASHRASNRASp21 RasRas GTPaseKirsten rat sarcoma virus oncogene homologHarvey rat sarcoma virus oncogene homologNeuroblastoma RAS viral oncogene homolog
02

Mechanism of action

Covalent inhibition of the inactive GDP-bound state of mutant Ras proteins (specifically G12C), allosteric inhibition of the switch II pocket, and inhibition of farnesyltransferase to prevent membrane localization.

03

Biological functions

Signal transductionCell proliferationCell survivalCell differentiationCell migrationApoptosis regulation
04

Disease associations

CancerRASopathiesNoonan syndromeCostello syndromeCardiofaciocutaneous syndrome
05

Safety considerations

Hepatotoxicity (elevated ALT/AST)Gastrointestinal toxicity (diarrhea, nausea)Acquired drug resistance via bypass signalingOff-target effects on wild-type Ras
06

Interacting drugs

Sotorasib

7 more in the full profile.

07

Biomarkers

KRAS G12C mutationKRAS G12D mutationNRAS mutationHRAS mutationpERK levels

Beyond the preview

Go deeper on Rat sarcoma virus oncogene homolog (Ras) (Ras).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rat sarcoma virus oncogene homolog (Ras) (Ras).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call